Meta-Analysis of Studies Evaluating the Effect of Cilostazol on Major Outcomes After Carotid Stenting

Conclusion: Cilostazol seems to decrease total ISR rates in patients undergoing CAS without affecting MI/stroke/death events, both in the early and late settings.

http://jet.sagepub.com/cgi/content/abstract/23/1/186?rss=1

Source: Journal of Endovascular Therapy - January 12, 2016 Category: Surgery Authors: Galyfos, G., Geropapas, G., Sigala, F., Aggeli, K., Sianou, A., Filis, K. Tags: Carotid Artery Stenting Source Type: research